Editorial Response to the Letter Relating to our Article "Predicting Adverse Events to Thiopurines in IBD: Are We a Step Closer?"

IF 4.5 3区医学 Q1 GASTROENTEROLOGY & HEPATOLOGY

Inflammatory Bowel Diseases Pub Date : 2024-10-24 DOI:10.1093/ibd/izae242

Mohmmed Tauseef Sharip, Miles Parkes, Sreedhar Subramanian

引用次数: 0

查看原文本刊更多论文

编辑部对有关我们的文章 "预测 IBD 硫嘌呤类药物的不良反应：我们是否更近了一步？

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Inflammatory Bowel Diseases 医学-胃肠肝病学

CiteScore

9.70

自引率

6.10%

发文量

462

审稿时长

1 months

期刊介绍： Inflammatory Bowel Diseases® supports the mission of the Crohn''s & Colitis Foundation by bringing the most impactful and cutting edge clinical topics and research findings related to inflammatory bowel diseases to clinicians and researchers working in IBD and related fields. The Journal is committed to publishing on innovative topics that influence the future of clinical care, treatment, and research.